From: Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
Patients | baseline creatinine | 24 month creatinine | baseline proteinuria1 | 24 month proteinuria1 | baseline cholesterol/ | 24 month cholesterol/ | baseline triglycerides | 24 month triglycerides |
---|---|---|---|---|---|---|---|---|
(mg/dL)/MDRD (ml/min/1.73m2) | (mg/dL)/ MDRD (ml/min/1.73m2) | (mg/mmol) | (mg/mmol) | HDL/LDL | HDL/LDL | (mmol/L) | (mmol/L) | |
(mmol/L) | (mmol/L) | |||||||
1 | 0.84 /76 | 0.78/81 | 6.1 | 12.1 | 159/89/90 | 184/74/101 | 45 | 52 |
2 | 0.93/>90 | 0.95/>90 | 22.4 | 40.0 5 | 118/46/72 | 167/54/100 | 43 | 63 |
3 | 1.22/74 | 22.5 | 2 | 205/74/131 | 86 | |||
4 | 0.96/71 | 10.3 | 3 | 176/83/94 | 3 | 144 | 3 | |
5 | 0.99/87 | 0.97/88 | 9.1 | 8.2 | 202/63/139 | 181/44/125 4 | 116 | 64 |
6 | 0.67/>90 | 0.58/>90 | 5.0 | 9.6 | 240/86/156 | 152/63/89 4 | 198 | 116 |
7 | 1.15/50 0 | 0.98/60 | 9.4 | 28.6 5 | 192/78/114 | 188/77/102 | 47 | 47 |
8 | 1.07/83 | 1.09/80 | 5.6 | 4.0 | 154/56/98 | 202/66/120 | 62 | 77 |
9 | 0.77/>90 | 0.86/>90 | 13.2 | 47.0 5 | 125/36/90 | 226/52/136 4 | 102 | 186 |
10 | 0.85/78 | 0.77/87 | 5.0 | 4.3 | 212/55/157 | 167/75/82 4 | 48 | 51 |
11 | 0.71/>90 0 | 0.86/78 | 7.7 | 9.4 | 94/40/54 | 118/41/64 | 76 | 62 |
12 | 0.42/> 90 | 0.48/>90 | 13.3 | 11.1 | 142/38/104 | 193/42/127 | 117 | 120 |
13 | 0.62/>90 | 0.61/>90 | 6.6 | 9.8 | 183/96/87 | 163/84/90 | 53 | 41 |
14 | 0.83/>90 | 1.01/>90 | 6.4 | 8.9 | 203/83/120 | 176/39/104 4 | 175 | 163 |
15 | 0.68/>90 | 0.69/>90 | 9.0 | 18.2 | 200/78/122 | 170/75/80 | 66 | 73 |
16 | 0.62/>90 | 0.54/>90 | 12.9 | 11.9 | 156/51/105 | 120/49/50 4 | 145 | 104 |
17 | 1.30/42 0 | 1.24/44 | 22.4 | 32.3 5 | 292/106/189 | 216/69/147 4 | 243 | 117 |